Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, ...

In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...

Shares of Altimmune rose on positive trial results for its treatment for metabolic dysfunction-associated steatohepatitis, or MASH, a liver disease. The stock climbed 7.5% to $5.43 in premarket ...

The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...

Taking daily aspirin may prevent progression of nonalcoholic fatty liver disease (NAFLD) to liver fibrosis and nonalcoholic steatopepatitis (NASH), according to a study published online May 8 in ...

Medically reviewed by Allison Herries, RDN Diet sodas do not cause liver injury in the same way that alcohol, viral hepatitis ...

The liver, hidden deep in the abdomen, often signals trouble through visible changes on the face, according to three leading ...

As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease and resulting liver scarring or cirrhosis also are rising. Patients are ...

Your face serves as a remarkable window into your overall health, often revealing internal problems long before you experience obvious symptoms. When it comes to fatty liver disease, one of the most ...